MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
ALX Oncology Holdings EBITDA per Share 2011-2026 | ALXO
Annual EBITDA per Share ALX Oncology Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.71 | -3.94 | -3.12 | -2.07 | -2.35 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.07 | -3.94 | -2.84 |
Quarterly EBITDA per Share ALX Oncology Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.42 | -0.49 | -0.59 | - | -0.61 | -0.8 | -0.75 | - | -1.29 | -0.89 | -0.78 | - | -0.9 | -0.83 | -0.61 | - | -0.61 | -0.4 | -0.35 | - | -0.32 | -3.35 | -1.63 | - | -0.88 | -1.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.32 | -3.35 | -0.889 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Apellis Pharmaceuticals
APLS
|
0.45 | $ 20.7 | -1.24 % | $ 2.61 B |  USA |
 |
Aptorum Group Limited
APM
|
0.34 | $ 0.84 | - | $ 4.58 M |  China |
 |
Axsome Therapeutics
AXSM
|
-3.34 | $ 166.38 | - | $ 8.28 B | USA |
 |
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | China |
 |
Burford Capital Limited
BUR
|
1.11 | $ 8.73 | 3.44 % | $ 1.36 B |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M |  France |
 |
AbCellera Biologics
ABCL
|
-0.67 | $ 3.82 | - | $ 1.14 B |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | Britain |
 |
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | USA |
 |
Capricor Therapeutics
CAPR
|
-0.86 | $ 26.86 | -3.83 % | $ 719 M | USA |
 |
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | USA |
 |
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | Canada |
 |
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | Germany |
 |
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | USA |
 |
Codexis
CDXS
|
-0.73 | $ 1.02 | - | $ 74.9 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
-408 | $ 3.34 | 0.3 % | $ 1.2 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M |  Israel |
 |
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | USA |
 |
Agios Pharmaceuticals
AGIO
|
-8.05 | $ 29.2 | -3.41 % | $ 1.69 B | USA |
 |
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | USA |
 |
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | USA |
 |
Завод ДИОД
DIOD
|
2.37 | - | - | - | Russia |
 |
Фармсинтез
LIFE
|
-0.23 | - | - | - | Russia |
 |
Albireo Pharma
ALBO
|
-6.41 | - | -0.23 % | $ 916 M | USA |
 |
Cellectis S.A.
CLLS
|
-2.92 | $ 3.8 | -2.06 % | $ 116 M | France |
 |
Alector
ALEC
|
-1.46 | $ 2.21 | -9.05 % | $ 228 M | USA |
 |
Entera Bio Ltd.
ENTX
|
-0.6 | $ 1.37 | -1.44 % | $ 62.8 M | Israel |
 |
Allena Pharmaceuticals
ALNA
|
-0.696 | - | 3.16 % | $ 1.9 M | USA |
 |
Aileron Therapeutics
ALRN
|
-3.63 | - | 10.36 % | $ 9.8 M | USA |
 |
Altimmune
ALT
|
-1.45 | $ 4.16 | - | $ 295 M | USA |
 |
Teligent, Inc.
TLGT
|
8.97 | - | -13.85 % | $ 16.1 M | USA |
 |
AlloVir
ALVR
|
-44.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
1.54 | - | - | $ 2.91 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.15 | - | -11.43 % | $ 502 K | USA |
 |
Amarin Corporation plc
AMRN
|
-0.11 | $ 13.93 | 0.94 % | $ 5.78 B |  Irlanda |
 |
AbbVie
ABBV
|
8.95 | $ 234.26 | 0.94 % | $ 414 B | USA |
 |
Blueprint Medicines Corporation
BPMC
|
0.26 | - | - | $ 8.14 B | USA |
 |
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | USA |
 |
AIM ImmunoTech
AIM
|
-0.41 | $ 0.77 | -14.64 % | $ 37 M | USA |